Publication 2026
706.
Biglari S, Jaimes-Campos MA, Siwy J, Latosinska A, Mischak M, Nawrot TS, Staessen JA, Martens DS, Banasik M.
A kidney-conditioned urinary peptidomic biological ageing clock predicts all-cause mortality and age-related health outcomes
medRxiv 2026, 2026.09.01.26361640.
705.
Hoffmann M, Makridakis M, Reese TF, Schmitz J, Roubelakis M, Paschidis K, Strogilos R, Latosinska A, Frantzi M, Niegisch G, Mischak H, Antonia V, Mokou M.
New preclinical evidence supporting Cephaeline as a candidate therapy for bladder cancer
Oncol Res Treat 2026, 49(Suppl1): 296.
704.
Liu CH, Martens DS, An DW, Siwy J, Latosinska A, Pellicori P, Verdonschot JAJ, Ahmed FZ, Wei FF, Rossignol P, Petutschnigg J, Heymans S, Cuthbert JJ, Yu YL, Girerd N, Clark AL, Verhamme P, Zhang DY, Li Y, Nawrot TS, Cleland JG, Zannad F, Mischak H, Staessen JA; HOMAGE investigators.
Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial
EBioMedicine. 2026, 130:106406. Epub 2026 Jul 30.
703.
Kondyli M, Siwy J, Jaimes Campos MA, Amann K, Beige J, Keller F, Mischak H, Frantzi M, Wendt R, Rossing P, Rupprecht H, Catanese L, Jankowski V.
Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy
Diabetes Res Clin Pract. 2026, 238:113396. Epub 2026 Jun 26.
702.
Robberechts T, Stoenoiu MS, Soliveri L, Kiernan A, Canning C, Latosinska A, Smajda S, Hammer F, Pascarella R, Caroli A, Mischak H, Zedde M, Persu A.
Fibromuscular Dysplasia: Emerging Concepts Beyond the International Consensus
Hypertension. 2026 Jul;83(7):e25633. Epub 2026 Apr 29.
701.
Landau J, Unterman I, Tzukert K, Frantzi M, Mischak H, Boutin L, Depret F, Latosinka A, Ilan Y.
Dynamics in kidney function markers as predictors of post-ICU survival: an innovative approach to enhance marker accuracy
Front Med (Lausanne). 2026, 13:1765919.
700.
Frantzi M, Ahangar M, Vlahou A, Mischak H, Solia I, Theodorakakou F, Liacos CI, Zoidakis J, Terpos E, Dimopoulos MA, Kastritis E.
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma
Proteomics. 2026, 19:e70143.
699.
Król-Kulikowska M, Kepinska M, Siwy J, Keller F, Mischak H, Wendt R, Sarenmalm E, Nilsson Å, Peters B, Dudoignon E, Zunara F, Michel M, Salgueira M, Spasovski G, Scholz C, Wawrzonkowski P, Banasik M; UriCoV Working Group.
Post-Acute Sequelae of COVID-19 (PASC) in Hospitalized and Ambulatory Patients: A Comparative Study
J Clin Med. 2026, 15(10):3681.
698.
Latosinska A, Stoenoiu MS, Delmotte P, Bruno RM, Lopez-Sublet M, Jaimes Campos MA, Staessen JA, Delles C, Vikkula M, Mischak H, Adlam D, Persu A.
Spontaneous coronary artery dissection (SCAD) and fibromuscular dysplasia (FMD) do not share an identical urinary proteomic signature, even though they frequently overlap clinically
Journal of Hypertension. 2026, 44(Suppl1):e81
697.
Ahangar M, Mischak H, Moulavasilis N, Stravodimos K, Mahjoubi F, Jankowski J, Frantzi M, Vlahou A.
Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer
Proteomics. 2026, 26(7):169-180. Epub 2026 Apr 27.
696.
Frantzi M, Keller F, Latosinska A, Beige J, Mebazaa A, Caillard A, An D, Perco P, Schanstra JP, Catanese L, Wendt R, Rupprecht H, Staessen JA, Vlahou A, Mischak H, Siwy J.
Urinary Collagen Peptides Predict Mortality
Proteomics. 2026, 26(7):98-110. Epub 2026 Apr 9.
695.
Nguyen TMN, Kondyli M, Mischak H, Keller F, Beige J, Latosinska A, Siwy J.
Association of Urinary Complement Peptides with Kidney Function and Progression of Kidney Disease
Int J Mol Sci. 2026, 27(4):1982.
694.
Gonidaki C, Latosinska A, Vlahou A, Stroggilos R, Mischak H.
Practical Impact of Imputation and Batch-Effect Correction for Proteomics/Peptidomics Differential-Abundance Analysis
Proteomics 2026, 18:e70111.
693.
Frantzi M, Tymoszuk P, Salcher S, Gomez-Gomez E, Morillo AC, Melchior F, Blanca A, Mischak H, Vlahou A, Pircher A, Heidegger I.
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles
Eur Urol Oncol. 2026, 9(1):17-25.
692.
Gómez Gómez E, Morillo A, Jobre KN, Lendinez G, Blanca A, Lopez Ruiz D, Parada J, Heidegger I, Culig Z, Lopez-Beltran A, Carrasco-Valiente J, Mischak H, Medina-López RA, Campos Hernandez J, Frantzi M.
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naive patients
Research Square. posted 08 Mar, 2026.
691.
Devos H, Makridakis M, Stroggilos R, Campos MAJ, Tserga A, Mokou M, Roubelakis MG, Zoidakis J, Vlahou A, Latosinska A.
A Proteomics Resource Investigating Fibrosis: Proof-of-Concept for Identifying Novel Drug Candidates
Proteomics. 2026, 26(1):94-99.
690.
Gülmez D, Siwy J, Kurz K, Wendt R, Banasik M, Peters B, Dudoignon E, Depret F, Salgueira M, Nowacki E, Kurnikowski A, Mussnig S, Krenn S, Gonos S, Löffler-Ragg J, Weiss G, Mischak H, Hecking M, Schernhammer E, Beige J, and UriCoV working group.
Urinary Peptidomic Profiling in Post-Acute Sequelae of SARS-CoV-2 Infection: A Case-Control Study
Proteomics. 2026, 26(1):32-43.